United States (US) Biopsy Procedures Count by Segments and Forecast to 2030

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$2995
Buy Report Download FREE Resources

Published: March 28, 2023 Report Code: GDMEPD0801C031-ST

Select Item

US Biopsy Procedures Market Overview

In 2022, the total number of Biopsy Procedures conducted in the US was 8,906,287. The biopsy procedure is used to take samples of a patient’s body cells or tissue so that they may be examined in a lab. If the person exhibits specific signs and symptoms or if the doctor has found a problem area, then a biopsy might be required.

The US Biopsy Procedures market is a comprehensive databook report, covering key procedure data on the US Biopsy Procedures. The report also provides procedure volumes within segments – such as Biopsy Procedures for Other Indications, Breast Biopsy Procedures, Chronic Kidney Disease Biopsy Procedures, Cirrhosis Biopsy Procedures, Colorectal Biopsy Procedures, Kidney Transplant Biopsy Procedures, Leukemia Biopsy Procedures, Liver Biopsy Procedures, Liver Transplant Biopsy Procedures, Lung Biopsy Procedures, Prostate Biopsy Procedures, Skin Biopsy Procedures, and Thyroid Biopsy Procedures.

US Biopsy Procedures Market Segments

Some of the key segments in the US Biopsy Procedures market are Biopsy Procedures for Other Indications, Colorectal Biopsy Procedures, Skin Biopsy Procedures, Breast Biopsy Procedures, Lung Biopsy Procedures, Prostate Biopsy Procedures, Chronic Kidney Disease Biopsy Procedures, Leukemia Biopsy Procedures, Liver Biopsy Procedures, and Thyroid Biopsy Procedures. In 2022, Breast Biopsy Procedures was the leading segment in the US Biopsy Procedures market.

Skin Biopsy Procedures: This procedure is done to remove cells or skin samples from the body for laboratory examination. Skin biopsy is used to diagnose skin conditions and remove abnormal tissues.

Colorectal Biopsy Procedures: In this procedure, a small piece of tissue is removed from the rectum for examination. This can be further segmented into Colorectal Biopsy Procedures using Biopsy Forceps and Colorectal Biopsy Procedures using Biopsy Needles.

Breast Biopsy Procedures: This procedure is done to remove a sample of breast tissue for testing in the lab by specialists to provide a diagnosis. Breast Biopsy Procedures include sub-segments such as Breast These procedures can be further segmented into Biopsy Gun Procedures, Breast Biopsy Needle Procedures, and Breast Biopsy Procedures using Vacuum-Assisted Needle Devices.

US Biopsy Procedures Market Analysis, by Segments, 2022 (%)

US Biopsy Procedures Market Analysis, by Segments, 2022 (%)

For more segment insights into the US Biopsy Procedures market, download a free report sample

US Biopsy Procedures Market Report Overview

Market Size (2022) 8,906,287 Procedures
Forecast Period 2023-2030
Historical Period 2015-2022
Key Segments Biopsy Procedures for Other Indications, Colorectal Biopsy Procedures, Skin Biopsy Procedures, Breast Biopsy Procedures, Lung Biopsy Procedures, Prostate Biopsy Procedures, Chronic Kidney Disease Biopsy Procedures, Leukemia Biopsy Procedures, Liver Biopsy Procedures, and Thyroid Biopsy Procedures

Segments Covered in the Report

US Biopsy Procedures Market Segments Outlook (Number of Procedures, 2015-2030)

  • Biopsy Procedures for Other Indications
    • Biopsy Procedures for Other Indications using Biopsy Guns
    • Biopsy Procedures for Other Indications using Biopsy Forceps
    • Biopsy Procedures for Other Indications using Biopsy Needles
    • Biopsy Procedures for Other Indications using Biopsy Punches
  • Colorectal Biopsy Procedures
    • Colorectal Biopsy Procedures using Biopsy Forceps
    • Colorectal Biopsy Procedures using Biopsy Needles
  • Skin Biopsy Procedures
    • Skin Biopsy Procedures using Biopsy Punches
  • Breast Biopsy Procedures
    • Breast Biopsy Procedures using Vacuum-Assisted Needle Devices
    • Breast Biopsy Procedures using Biopsy Guns
    • Breast Biopsy Procedures using Biopsy Needles
  • Lung Biopsy Procedures
    • Lung Biopsy Procedures using Biopsy Guns
    • Lung Biopsy Procedures using Biopsy Forceps
    • Lung Biopsy Procedures using Biopsy Needles
  • Prostate Biopsy Procedures
    • Prostate Biopsy Procedures using Biopsy Guns
    • Prostate Procedures using Biopsy Needles
    • Prostate Biopsy Procedures using Biopsy Punches
  • Chronic Kidney Disease Biopsy Procedures
    • Chronic Kidney Disease Biopsy Procedures using Biopsy Guns
    • Chronic Kidney Disease Biopsy Procedures using Biopsy Needles
  • Leukemia Biopsy Procedures
    • Leukemia Biopsy Procedures using Biopsy Needles
  • Liver Biopsy Procedures
    • Liver Biopsy Procedures using Biopsy Guns
    • Liver Biopsy Procedures using Biopsy Needles
  • Thyroid Biopsy Procedures
    • Thyroid Biopsy Procedures using Biopsy Needles
    • Thyroid Biopsy Procedures using Biopsy Guns
  • Cirrhosis Biopsy Procedures
    • Cirrhosis Biopsy Procedures using Biopsy Guns
    • Cirrhosis Biopsy Procedures using Biopsy Needles
  • Kidney Transplant Biopsy Procedures
    • Kidney Transplant Biopsy Procedures using Biopsy Guns
    • Kidney Transplant Biopsy Procedures using Biopsy Needles
  • Liver Transplant Biopsy Procedures
    • Liver Transplant Biopsy Procedures using Biopsy Guns
    • Liver Transplant Biopsy Procedures using Biopsy Needles

Reasons to Buy

The US Biopsy Procedures report helps you to develop –

  • Business strategies by identifying the key segments poised for strong growth in the future.

  • Market-entry and market expansion strategies.

  • Investment strategies by identifying the key segments expected to register strong growth in the near future.

Table of Contents

  • 1. Report Guidance

  • 2. GlobalData Clinical Trials Report Coverage

  • 3. Clinical Trials by Region

    • 3.1. Clinical Trials and Average Enrollment by Country

      • 3.1.1. Top Five Countries Contributing to Clinical Trials in Asia-Pacific

      • 3.1.2. Top Five Countries Contributing to Clinical Trials in Europe

      • 3.1.3. Top Countries Contributing to Clinical Trials in North America

      • 3.1.4. Top Five Countries Contributing to Clinical Trials in Middle East and Africa

      • 3.1.5. Top Five Countries Contributing to Clinical Trials in Central and South America

  • 4. Clinical Trials by G7 Countries: AML to Central Nervous System Clinical Trials

  • 5. Clinical Trials by Phase in G7 Countries

  • 6. Clinical Trials in G7 Countries by Trial Status

  • 7. Clinical Trials by E7 Countries: AML to Central Nervous System Clinical Trials

  • 8. Clinical Trials by Phase in E7 Countries

  • 9. Clinical Trials in E7 Countries by Trial Status

  • 10. Clinical Trials by Phase

    • 10.1. In Progress Trials by Phase

  • 11. Clinical Trials by Trial Status

  • 12. Clinical Trials by End Point Status

  • 13. Subjects Recruited Over a Period of Time

  • 14. Clinical Trials by Sponsor Type

  • 15. Prominent Sponsors

    • 15.1. Top Companies Participating in AML Therapeutics Clinical Trials

  • 16. Prominent Drugs

  • 17. Clinical Trial Profile Snapshots

  • 18. Appendix

    • 18.1. Abbreviations

    • 18.2. Definitions

    • 18.3. Research Methodology

    • 18.4. Secondary Research

    • 18.5. About GlobalData

    • 18.6. Contact Us

  • 19. Source Table of Contents

  • 1.1 List of Tables

  • 1.2 List of Figures

  • 2 Introduction

  • 2.1 What Is This Report About?

  • 2.2 Biopsy Procedures, Segmentation

  • 2.3 Definitions of Procedures Covered in the Report

  • 3 Biopsy Procedures, United States

  • 3.1 Biopsy Procedures, United States, 2015-2030

    • 3.1.1 Biopsy Procedures for Other Indications, United States, 2015-2030

    • 3.1.2 Breast Biopsy Procedures, United States, 2015-2030

    • 3.1.3 Chronic Kidney Disease Biopsy Procedures, United States, 2015-2030

    • 3.1.4 Cirrhosis Biopsy Procedures, United States, 2015-2030

    • 3.1.5 Colorectal Biopsy Procedures, United States, 2015-2030

    • 3.1.6 Kidney Transplant Biopsy Procedures, United States, 2015-2030

    • 3.1.7 Leukemia Biopsy Procedures, United States, 2015-2030

    • 3.1.8 Liver Biopsy Procedures, United States, 2015-2030

    • 3.1.9 Liver Transplant Biopsy Procedures, United States, 2015-2030

    • 3.1.10 Lung Biopsy Procedures, United States, 2015-2030

    • 3.1.11 Prostate Biopsy Procedures, United States, 2015-2030

    • 3.1.12 Skin Biopsy Procedures, United States, 2015-2030

    • 3.1.13 Thyroid Biopsy Procedures, United States, 2015-2030

  • 4 Appendix

  • 4.1 Research Methodology

    • 4.1.1 Coverage

    • 4.1.2 Secondary Research

    • 4.1.3 Primary Research

    • 4.1.4 Market Modeling and Forecasting

    • 4.1.5 Company Share Analysis

    • 4.1.6 Distribution Share Analysis

    • 4.1.7 Benchmarking

  • 4.2 GlobalData Consulting

  • 4.3 Contact Us

  • 4.4 Disclaimer

Table

List of Tables

Table 1: Biopsy Procedures, United States, 2015-2022 11

Table 2: Biopsy Procedures, United States, 2023-2030 13

Table 3: Biopsy Procedures for Other Indications, United States, 2015-2022 15

Table 4: Biopsy Procedures for Other Indications, United States, 2023-2030 17

Table 5: Breast Biopsy Procedures, United States, 2015-2022 19

Table 6: Breast Biopsy Procedures, United States, 2023-2030 21

Table 7: Chronic Kidney Disease Biopsy Procedures, United States, 2015-2022 23

Table 8: Chronic Kidney Disease Biopsy Procedures, United States, 2023-2030 25

Table 9: Cirrhosis Biopsy Procedures, United States, 2015-2022 27

Table 10: Cirrhosis Biopsy Procedures, United States, 2023-2030 29

Table 11: Colorectal Biopsy Procedures, United States, 2015-2022 31

Table 12: Colorectal Biopsy Procedures, United States, 2023-2030 33

Table 13: Kidney Transplant Biopsy Procedures, United States, 2015-2022 35

Table 14: Kidney Transplant Biopsy Procedures, United States, 2023-2030 37

Table 15: Leukemia Biopsy Procedures, United States, 2015-2022 39

Table 16: Leukemia Biopsy Procedures, United States, 2023-2030 41

Table 17: Liver Biopsy Procedures, United States, 2015-2022 43

Table 18: Liver Biopsy Procedures, United States, 2023-2030 45

Table 19: Liver Transplant Biopsy Procedures, United States, 2015-2022 47

Table 20: Liver Transplant Biopsy Procedures, United States, 2023-2030 49

Table 21: Lung Biopsy Procedures, United States, 2015-2022 51

Table 22: Lung Biopsy Procedures, United States, 2023-2030 53

Table 23: Prostate Biopsy Procedures, United States, 2015-2022 55

Table 24: Prostate Biopsy Procedures, United States, 2023-2030 57

Table 25: Skin Biopsy Procedures, United States, 2015-2022 59

Table 26: Skin Biopsy Procedures, United States, 2023-2030 61

Table 27: Thyroid Biopsy Procedures, United States, 2015-2022 63

Table 28: Thyroid Biopsy Procedures, United States, 2023-2030 65

Table 29: Total Number of Primary Research Participants, General Surgery Market, by Country 68

Figures

List of Figures

Figure 1: Biopsy Procedures, United States, 2015-2022 10

Figure 2: Biopsy Procedures, United States, 2023-2030 12

Figure 3: Biopsy Procedures for Other Indications, United States, 2015-2022 14

Figure 4: Biopsy Procedures for Other Indications, United States, 2023-2030 16

Figure 5: Breast Biopsy Procedures, United States, 2015-2022 18

Figure 6: Breast Biopsy Procedures, United States, 2023-2030 20

Figure 7: Chronic Kidney Disease Biopsy Procedures, United States, 2015-2022 22

Figure 8: Chronic Kidney Disease Biopsy Procedures, United States, 2023-2030 24

Figure 9: Cirrhosis Biopsy Procedures, United States, 2015-2022 26

Figure 10: Cirrhosis Biopsy Procedures, United States, 2023-2030 28

Figure 11: Colorectal Biopsy Procedures, United States, 2015-2022 30

Figure 12: Colorectal Biopsy Procedures, United States, 2023-2030 32

Figure 13: Kidney Transplant Biopsy Procedures, United States, 2015-2022 34

Figure 14: Kidney Transplant Biopsy Procedures, United States, 2023-2030 36

Figure 15: Leukemia Biopsy Procedures, United States, 2015-2022 38

Figure 16: Leukemia Biopsy Procedures, United States, 2023-2030 40

Figure 17: Liver Biopsy Procedures, United States, 2015-2022 42

Figure 18: Liver Biopsy Procedures, United States, 2023-2030 44

Figure 19: Liver Transplant Biopsy Procedures, United States, 2015-2022 46

Figure 20: Liver Transplant Biopsy Procedures, United States, 2023-2030 48

Figure 21: Lung Biopsy Procedures, United States, 2015-2022 50

Figure 22: Lung Biopsy Procedures, United States, 2023-2030 52

Figure 23: Prostate Biopsy Procedures, United States, 2015-2022 54

Figure 24: Prostate Biopsy Procedures, United States, 2023-2030 56

Figure 25: Skin Biopsy Procedures, United States, 2015-2022 58

Figure 26: Skin Biopsy Procedures, United States, 2023-2030 60

Figure 27: Thyroid Biopsy Procedures, United States, 2015-2022 62

Figure 28: Thyroid Biopsy Procedures, United States, 2023-2030 64

Frequently asked questions

United States (US) Biopsy Procedures Count by Segments and Forecast to 2030 standard reports
Currency USD
$2,995

Can be used by individual purchaser only

Most Popular
$5,990

Can be shared by unlimited users within one corporate location e.g. a regional office

$8,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

United States (US) Biopsy Procedures Count by Segments and Forecast to 2030 was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Biopsy Devices reports
Medical Devices
New
Sutures Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and…
$7,500 | June 2026
Medical Devices
New
Traditional Wound Management Market Size by Segments, Share, Regulatory, Reimbursement,…
$7,500 | June 2026
Medical Devices
New
Neurovascular Accessory Devices Market Size by Segments, Share, Regulatory, Reimbursement,…
$7,500 | June 2026
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at United States (US) Biopsy Procedures Count by Segments and Forecast to 2030 in real time.

  • Access a live United States (US) Biopsy Procedures Count by Segments and Forecast to 2030 dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more